Cardiovascular disease in rheumatoid arthritis: single-center hospital-based corhort study in France {lozenge, open}{lozenge, open}Pour citer cet article, utiliser ce titre en anglais et sa référence dans le même volume de Joint Bone Spine.;Morbimortalité cardiovasculaire au cours de la polyarthrite rhumatoïde : étude de cohorte hospitalière monocentrique française

Revue du Rhumatisme (Edition Francaise)

Volumn 74, Issue 1, 2007, Pages 72-78

  Assous, Noémie ^a   Touzé, Emmanuel ^b   Meune, Christophe ^c   Kahan, André ^a   Allanore, Yannick ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CENTRE HOSPITALIER SAINTE ANNE   (France)

^c Institut Cochin   (France)

Author keywords

Cardiovascular event; Mortality; Myocardial infarction; Rheumatoid arthritis; Stroke

Indexed keywords

EID: 33846620048     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rhum.2006.05.019     Document Type: Article

References (39)

1. Saraux A., Guedes C., Allain J., Devauchelle V., Valls I., Lamour A., et al. Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France. Société de rhumatologie de l'Ouest. J. Rheumatol. 26 (1999) 2622-2627
2. Wallberg-Jonsson S., Ohman M.L., and Dahlqvist S.R. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J. Rheumatol. 24 (1997) 445-451
3. Watson D.J., Rhodes T., and Guess H.A. All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J. Rheumatol. 30 (2003) 1196-1202
4. Solomon D.H., Karlson E.W., Rimm E.B., Cannuscio C.C., Mandl L.A., Manson J.E., et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107 (2003) 1303-1307
5. Gabriel S.E., Crowson C.S., Kremers H.M., Doran M.F., Turesson C., O'Fallon W.M., et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum. 48 (2003) 54-58
6. Maradit-Kremers H., Nicola P.J., Crowson C.S., Ballman K.V., and Gabriel S.E. Cardiovascular death in rheumatoid arthritis. Arthritis Rheum. 52 (2005) 722-732
7. Myllykangas-Luosujarvi R., Aho K., Kautiainen H., and Isomaki H. Cardiovascular mortality in women with rheumatoid arthritis. J. Rheumatol. 22 (1995) 1065-1067
8. Navarro-Cano G., Del Rincon I., Pogosian S., Roldan J.F., and Escalante A. Association of mortality with disease severity in rheumatoid arthritis, independent of comorbidity. Arthritis Rheum. 48 (2003) 2425-2433
9. Wolfe F., Michaud K., Gefeller O., and Choi H.K. Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum. 48 (2003) 1530-1542
10. Wolfe F., Freundlich B., and Straus W.L. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J. Rheumatol. 30 (2003) 36-40
11. Del Rincon I.D., Williams K., Stern M.P., Freeman G.L., and Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 442 (2001) 2737-2745
12. Fischer L.M., Schlienger R.G., Matter C., Jick H., and Meier C.R. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am. J. Cardiol. 93 (2004) 198-200
13. Maradit-Kremers H., Crowson C.S., Nicola P.J., Ballman K.V., Roger V.L., Jacobsen S.J., et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis. Arthritis Rheum. 52 (2005) 402-411
14. Turesson C., Jarenros A., and Jacobson L. Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann. Rheum. Dis. 63 (2004) 952-955
15. Bjornadal L., Baecklund E., Yin L., Granath F., Klareskog L., and Ekbom A. Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95. J. Rheumatol. 29 (2002) 906-912
16. Solomon D.H., Curhan G.C., Rimm E.B., Cannuscio C.C., and Karlson E.W. Cardiovascular risks in women with and without rheumatoid arthritis. Arthritis Rheum. 50 (2004) 3344-3349
17. Dessein P.H., Joffe B.I., Veller M.G., Stevens B.A., Tobias M., Reddi K., et al. Traditional and non traditional cardiovascular risks factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol 32 (2005) 435-442
18. Gonzales-Gay M.A., Gonzalez-Juanatey C., Pineiro A., Garcia-Porrua C., and Testa A. Llorca l. High-grade C-Reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J. Rheumatol. 32 (2005) 1219-1223
19. Del Rincon I., Williams K., Stern M.P., Freeman G.L., O'Leary D.H., and Escalante A. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum. 48 (2003) 1833-1840
20. Wallberg-Jonsson S., Johanson S., Ohman M.L., and Rantapaa-Dahlqvist S. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J. Rheumatol. 26 (1999) 2562-2571
21. Weyand C.M., Gornzy J.J., Luizzo G., Kopecky S.L., and Holmes D.R. Frye RLl. T-cell immunity in acute coronary syndromes. Mayo Clin. Proc. 76 (2001) 1011-1020
22. Arnett F.C., Edworthy S.M., Bloch D.A., Mc Shane D.J., Fries J.F., Cooper N.S., et al. The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31 (1988) 315-324
23. Wong S.Y., Kwok T., Woo J., Lynn H., Griffith J.F., Leung J., et al. Bone mineral density and the risk of peripheral arterial disease in men and women: results for Mr Wong and Ms Os, Hong Kong. Osteoporos. Int. 16 (2005) 1933-1938
24. De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J., et al. European guidelines on cardiovascular disease prevention in clinical practice: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur. Heart J. 24 (2003) 1601-1610
25. Lemesle M., Milan C., Faivre J., Moreau T., Giroud M., and Dumas R. Incidence trends of ischemic stroke and transient ischemic attacks in a well-defined French population from 1985 through 1994. Stroke 30 (1999) 371-377
26. Del Rincon I., Freeman G.L., Haas R.W., O'Leary D.H., and Escalante A. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum. 52 (2005) 3413-3423
27. Lindqvist E., and Eberhardt K. Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Ann. Rheum. Dis. 58 (1999) 11-14
28. Kroot E.J., Van Leewen M.A., Vas Rijswijk M.H., Prevoo M.L., Van'tHof M.A., Van de Putte L.B., et al. No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset. Ann. Rheum. Dis. 59 (2000) 954-958
29. Peltomaa R., Paimela L., Kautiainen J., and Leirisalo-Repo M. Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis. Ann. Rheum. Dis. 61 (2002) 889-894
30. Lodder M.C., de Jong Z., Kostense P.J., Molenaar E.T., Staal K., Voskuyl A.E., et al. Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density. Ann. Rheum. Dis. 63 (2004) 1576-1580
31. Maradit-Kremers H., Nicola P.J., Crowson C.S., Ballman K.V., and Gabriel S.E. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum. 50 (2004) 3450-3457
32. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342 (2000) 836-843
33. Hurlimann D., Forster A., Noll G., Enseleit F., Chenevard R., Distler O., et al. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 106 (2002) 2184-2187
34. Jacobsson L.T., Turesson C., Gulfe A., Kapetanovic M.C., Petersson I.F., Saxne T., et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J. Rheumatol. 32 (2005) 1213-1218
35. Choi H.K., Hernan M.A., Seeger J.D., Robins J.M., and Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359 (2002) 1173-1177
36. Hanania G., Cambou J.P., Gueret P., Vaur L., Blanchard D., Lablanche J.M., et al. USIC 2000 Investigators. Management and in-hospital outcome of patients with acute myocardial infarction admitted to intensive care units at the turn of the century: results from the French nationwide USIC 2000 registry. Heart 90 (2004) 1404-1410
37. Douglas K.M.J., Pace A.V., Treharne G.J., Saratzis A., Nightingale P., Erb N., et al. Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann. Rheum. Dis. 65 (2006) 348-353
38. Goodson N., Marks J., Lunt M., and Symmons D. Cardiovascular admission and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann. Rheum. Dis. 64 (2005) 1595-1601
39. Warrington K.J., Kent P.D., Frye R.L., Lymp J.F., Kopecky S.L., Goronzy J.J., et al. Rheumatoid arthritis in an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res. Ther. 7 (2005) 984-991